Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alveda Pharmaceuticals

Alveda Pharmaceuticals?uq=AFYHfsyn
2006 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Supplier of generic injectable pharmaceuticals and medical devices. The company supplies atropine sulphate, acetylcysteine, irinotecan, methylene blue, sterile water, piperacillin tazobactam, naloxone and epinephrine.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Medical Supplies
Parent Company
Primary Office
  • 40 Holy Street
  • Suite 801
  • Toronto, Ontario M4S 3C3
  • Canada

+1 (800) 000-0000

Alveda Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alveda Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Alveda Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Albert Beraldo Founder, President & Chief Executive Officer
Michael Bethell Chief Operating Officer